Last Updated : Thursday, July 9, 2020 13:59:29

Tag Archives: IQVIA

STRIDES PHARMA gets USFDA nod to sell medicine to treat tension, headache

BANGALORE / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Bangalore headquartered pharmaceutical products manufacturing Indian company Strides Pharma Sciences Ltd said of having got nod from USFDA (US Food and Drugs Administration) to sell medicine to treat tension (or muscle concentration) and headache. In a press-release titled,

ALEMBIC PHARMA gets USFDA nod to sell tablets to treat bacterial infections

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell tablets to cure bacterial infections. In a press-release titled, “Alembic Pharmaceuticals receives USFDA

ALEMBIC PHARMA gets USFDA nod to sell medicine to treat risk of stroke

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Alembic Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat risk of stroke and allied illness. In a press-release titled, “Alembic Pharmaceuticals receives USFDA Tentative

CIPLA gets DCGI nod to sell CIPREMI (Remdesivir lyophilized powder for injection)

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, pharmaceutical products manufacturing Indian company Cipla Ltd said of having got nod from USFDA to sell Cipremi (remdesivir lyophilized powder for injection 100 mg), which is an approved emergency use authorization (EUA) treatment for patients with severe COVID19 disease. In

Dr REDDY’s LAB launches medicine to treat prostate cancer in US Market

PRINCETON (NEW JERSEY, US) / HYDERABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Hyderabad headquartered Reddy family owned and managed pharmaceuticals products manufacturing Indian company Dr. Reddy’s Laboratories Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat prostate

Alembic JVC ALEOR DERMA gets USFDA nod to sell gel to treat pimples, cysts

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Amin family owned 100 years old pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having announced its joint-venture company Aleor Dermaceuticals having received USFDA (US Food & Drugs Administration) nod to sell

GLENMARK PHARMA gets USFDA nod to sell medicine to treat cough, cold

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing company Glenmark Pharmaceuticals Ltd said of having got a final nod from USFDA to sell medicine to treat cough and cold. In a press-release titled, “Glenmark Pharmaceuticals receives ANDA approval for Fingolimod Capsules, 0.5 mg”

ALEMBIC PHARMA gets USFDA nod to sell medicine to treat blood disorders

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara headquartered Amin family owned 100 years old pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having got a USFDA (US Food & Drugs Administration) nod to sell medicine to treat chronic iron overload in

CAPLIN STERILES gets USFDA nod to sell injection to treat low blood pressure

CHENNAI / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Chennai headquartered pharmaceutical products manufacturing Indian company Caplin Laboratories Ltd said of having got a nod from USFDA (US Food & Drugs Administration) to market to treat hypotension (abnormally low blood pressure). In a press-release titled, “CAPLIN STERILES

BIOCON and MYLAN gets USFDA nod to sell Semglee™, insulin glargine injection

HERTFORDSHIRE (ENGLAND) / PITTSBURGH (PENNSYLVANIA) / BENGALURU / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bengaluru headquartered Dr Kiran Mazumdar Shaw headed Biotechnology and Pharmaceutical products manufacturing Indian company Biocon Ltd jointly with Mylan N.V. said of having got a nod from USFDA (US Food & Drugs

LUPIN and MYLAN get nod to market biosimilar to treat psoriasis in EU

HERTFORDSHIRE (ENGLAND) / PITTSBURGH (US) / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical sector Indian company Lupin Ltd along with US based Mylan NV, said of having got marketing authorization for biosimilar to treat psoriasis. In a press-release titled, “Lupin and Mylan Receive European

US Court rules in favor of BIOCON’s partner MYLAN, for device patent dispute

BENGALURU / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bengaluru headquartered biotechnology sector Indian company engaged in pharmaceutical products manufacturing Biocon Ltd said of its partner Mylan having received favorable ruling from US Patent and Trademark Appeal Board (US PTAB) on Sanofi’s Four Device Patents for Lantus®

GLENMARK PHARMA gets USFDA nod to market pain-killer drug

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing Indian company – Glenmark Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to market painkiller drug – Chlorzoxazone Tablets USP in dosage value of 375 milligram (mg) and 750 mg.

CIPLA files ANDA for inhalation powder form of medicine, to treat asthma

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing Indian company Cipla Ltd said of having filed abbreviated new drug application (ANDA) for generic version of Glaxo SmithKline’s Advair Diskus® medicine, which shall be provided in inhalation power form of medicine, for asthma patients.

AUROBINDO PHARMA gets USFDA nod to sell medicine to treat infections

HYDERABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Hyderabad headquartered Pharmaceutical Products manufacturing Indian company Aurobindo Pharma Ltd said of having got nod to sell medicine to treat infections caused due to skin infections. In a press-release titled, “Aurobindo Pharma receives USFDA Approval for Flucytosine Capsules”,

JB CHEM & PHARMA gets USFDA nod to sell medicine to treat epilepsy

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Indian pharmaceutical products manufacturing company JB Chemicals & Pharmaceuticals Ltd said of having got USFDA (US Food and Drugs Administration) approval for the company’s abbreviated new drug application for treatment of epilepsy, according to which the company is

Do NOT follow this link or you will be banned from the site!